Djibouti vs Yemen: Share of people with HIV who receive antiretroviral therapy
Djibouti
25.0%
in 2024
Yemen
29.0%
in 2024
Djibouti rank
139th
Yemen rank
136th
Share of people with HIV who receive antiretroviral therapy over time
- Djibouti
- Yemen
How they compare
Yemen currently reports 29.0% against 25.0% in Djibouti, a difference of 4.0%.
That makes Yemen's figure about 1.2 times Djibouti's.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Yemen ahead.
Djibouti ranks 139th and Yemen ranks 136th of 143 countries.
Across the 3 decades both report, Djibouti averaged higher in 2 and Yemen in 1.
Head to head by decade
| Decade | Djibouti | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.1% | 0.8% | 1.3% | Djibouti |
| 2010s | 14.5% | 14.4% | 0.1% | Djibouti |
| 2020s | 22.8% | 25.8% | 3.0% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Djibouti or Yemen?
- Yemen, at 29.0% against 25.0% in Djibouti as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Djibouti and Yemen?
- 4.0%, with Yemen ahead.
- How many years of comparable data are there for Djibouti and Yemen?
- 25 years are reported by both, from 2000 to 2024.
- How do Djibouti and Yemen rank globally for share of people with hiv who receive antiretroviral therapy?
- Djibouti ranks 139th and Yemen ranks 136th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.